Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 30, 2000
Chromosomal aberrations induced in mice bone marrow by treating with cisplatin and irradiationF Würschmidt, M J Bardenheuer, W U Müller, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 1, 1991
Radiotherapy of the rhabdomyosarcoma R1H of the rat: split-course versus continuous fractionationF Würschmidt, H P Beck-Bornholdt, H Vogler, et al.Radiation Research|December 1, 1994
Impact of tumor stroma on expression of the tumor bed effect in R1H rat rhabdomyosarcomaM Baumann, F Würschmidt, A Twardy, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiationH P Beck-Bornholdt, M Omniczynski, E Theis, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 6, 1998
[One hundred years of radiotherapy. Historical origins and development of fractionated irradiation in German speaking countries]H Willers, H P Heilmann, H P Beck-BornholdtDeutsche Medizinische Wochenschrift (1946)|July 10, 1987
[Risk-adapted treatment of immunocytomas]R Klapp, A Calavrezos, R Kuse, et al.Onkologie|April 1, 1990
[High dose intensity with COP-BLAM in Hodgkin's disease with unfavorable risk factors]R Kuse, A Calavrezos, R Küchler, et al.Deutsche Medizinische Wochenschrift (1946)|December 23, 1983
[Prognostic differences in low-malignancy germinal center cell lymphomas and immunocytomas. Relationship to histological subtypes, stages and therapy]R Kuse, H P Heilmann, A Calavrezos, et al.Strahlentherapie|April 1, 1985
[Sequential polychemotherapy and large-field radiotherapy of non-Hodgkin's lymphoma]R Kuse, H P Heilmann, A Calavrezos, et al.Deutsche Medizinische Wochenschrift (1946)|February 27, 1987
[Long-term results in 172 highly malignant non-Hodgkin's lymphomas with special reference to older patients]R Kuse, A Calavrezos, H J Stellbrink, et al.Pageof 6